Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 358.10B P/E 39.00 EPS this Y 29.30% Ern Qtrly Grth 28.20%
Income 89.28B Forward P/E 28.02 EPS next Y 21.20% 50D Avg Chg -1.00%
Sales 244.24B PEG 92.40 EPS past 5Y 21.38% 200D Avg Chg 10.00%
Dividend N/A Price/Book 35.68 EPS next 5Y 2.80% 52W High Chg -8.00%
Recommedations 1.90 Quick Ratio 0.49 Shares Outstanding 4.45B 52W Low Chg 67.00%
Insider Own 0.00% ROA 25.24% Shares Float 3.19B Beta 0.20
Inst Own 9.31% ROE 99.87% Shares Shorted/Prior 3.24M/4.11M Price 158.34
Gross Margin 84.65% Profit Margin 36.55% Avg. Volume 1,289,590 Target Price 146.15
Oper. Margin 48.73% Earnings Date Aug 7 Volume 832,759 Change -2.10%
About Novo Nordisk A/S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Novo Nordisk A/S News
05/12/24 Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
05/11/24 Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
05/10/24 Novo Nordisk enters deal to develop obesity therapy
05/09/24 Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled
05/09/24 Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
05/09/24 3 Million Reasons Novo Nordisk Still Looks Like a Phenomenal Buy
05/09/24 Novo Nordisk Sets Sights on a Long-Lasting Successor to Its Weight Loss Blockbuster
05/09/24 Novo taps another Flagship startup in search for next obesity drugs
05/08/24 Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
05/08/24 Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?
05/07/24 13 Best Stocks That Will Always Grow
05/06/24 Trading in Novo Nordisk shares by board members, executives and associated persons
05/06/24 Novo Nordisk A/S - share repurchase programme
05/06/24 Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
05/06/24 Investors Pile Into Amgen in Search of Next Obesity Drug Payout
05/06/24 Novo Nordisk doses first subject in Phase I trial of NLRP3 inhibitor
05/04/24 Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
05/04/24 Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
05/03/24 Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
05/03/24 Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript
NVO Chatroom

User Image Owl13 Posted - 4 hours ago

$NVO Any feeback welcomed here - as a long term play? Yes?

User Image Juststartingout14 Posted - 17 hours ago

@MYFLAUT I sold all my $NVO and $NVDA. I believe in the science and we are just starting. Super excited to be on this journey! Even though it has been great to be on both above companies journey as well!

User Image PacAttackInc Posted - 2 days ago

$NVO Weight loss drugs are the new boom https://www.thenew.money/article/novo-nordisk-is-all-in-on-weight-loss-drugs

User Image stocksrream Posted - 2 days ago

$HIMS $LLY $NVO Hims coming for Ozempic and WeGovy, half the price, available to all. Just had a blowout earnings.

User Image Ro_Patel Posted - 2 days ago

$GOOGL DeepMind targeting the $100B+ AI drug discovery business w/ AlphaFold 3 - the first AI-designed drugs may be ready for testing in “next couple of years,” AlphaFold software was developed to predict the 3D structure of proteins & subsequently has received a significant upgrade. It can now model other molecules of biological importance, including DNA, and the interactions b/n antibodies produced by the immune system and the molecules of disease organisms. The software was developed by Google DeepMind and Isomorphic labs, a sibling company under parent Alphabet working on AI for biotech that is also led by Hassabis. In January, Isomorphic Labs announced that it would work with $LLY & $NVO on drug development.

User Image Comicguy Posted - 2 days ago

$NVO 131 plus next week imo.

User Image Keepitmoving Posted - 2 days ago

$NVO who is running with the bulls? The Apis bull that is!

User Image stocktrader1850 Posted - 2 days ago

$VKTX $NVO is a potential buyer inmo

User Image RoyceduPont Posted - 2 days ago

@EdPowell4Trump I think that there is 1 company that would love to do business with ALLR that little are talking about and that is $NVO

User Image GoSoftlanding Posted - 2 days ago

$NVO It maybe able to get out of the long 120's finally, all up to 130~131 next week. Strong support at 126 still well kept.

User Image GSMITH10107 Posted - 2 days ago

$NVAX long term I see this pulling a $NVO value move.. vaccines are in high demand and sanofi is legit... cash is king baby

User Image Comicguy Posted - 2 days ago

$NVO Just hold and be happy you did. ☺️

User Image Keepitmoving Posted - 2 days ago

$NVO NVO is a winning team. 💪

User Image SwingTrader3888Twits Posted - 2 days ago

$NVO nice

User Image CEODD Posted - 2 days ago

$NVO We will reach 138 again soon. Passed resistance level.

User Image cmsstudios Posted - 2 days ago

$NVO just went by resistance of $129.21, next two $131.45, the big one $138.00

User Image tkathlina Posted - 2 days ago

$NVO $NVO another use case for Ozempic? More revenue for Nvo? 🤔🤔🤔

User Image squueeze Posted - 2 days ago

$HIMS $LLY $NVO

User Image stocksrream Posted - 2 days ago

$HIMS $LLY $NVO

User Image Taastrup43 Posted - 2 days ago

$NVO Endnu en milliardaftale: Novo investerer i amerikansk biotekselskab Det danske medicinalfirma har indgået en milliardaftale med amerikanske Metaphore Biotechnologies, som er en del af Flagship Pioneering Medicines

User Image BTECHINV Posted - 2 days ago

@golfeveryday Agree with this, the high potential value imo that Cardiovascular-centric endpoints would bring in a p3 design to BP(s) is spot on. What $NVO did with the landmark SURMOUNT trials has begun the process of ushering in the transition towards the medical aspects of the Obesity GLP-1 space. This transition in hindsight will appear obvious, but many on WS still focused on simplistic top-line WL numbers from whatever p1 press release hits the wires, not yet aware of the undercurrent taking place in the space. PEMVIDUTIDE excels in my opinion in this newly evolving paradigm, hence why imo the company has used the language often that BP's "get it". Disclosure: Long Altimmune (Pemvidutide GLP-1/GlucagonR), not medical advice, not investment advice.

User Image stocksrream Posted - 3 days ago

$HIMS $LLY $NVO GLP-1s coming soon to a tele-health kingpin from an app on your phone!

User Image Comicguy Posted - 3 days ago

$NVO Went up since his moronic post. Another green trader trying to short something he should be long on. Thanks for the cash fool.

User Image BlondeAmbition Posted - 3 days ago

$LLY $NVO $WW $VKTX

User Image TalkMarkets Posted - 3 days ago

Can Weight Loss Companies Fuel Gains In Your Stock Portfolio? $LLY $NVO $WW https://talkmarkets.com/content/stocks--equities/can-weight-loss-companies-fuel-gains-in-your-stock-portfolio?post=444803

User Image BioRich Posted - 3 days ago

@JoeDirty feels great to be the best at something. In all sincerity I have $VKTX and $TERN ahead of $ALT and have for quite some time. Today's call didn't change anything, I'm fact it solidified my position. Hope all 3 make it and we have more options on the market instead of the $NVO monopoly.

User Image Keepitmoving Posted - 3 days ago

$NVO what a tool. The story is wonder drugs.

User Image BioRich Posted - 3 days ago

@CowPie_ she asked me why I was invested in it assuming I was because I was listening to the earnings call. She was relieved when I told her I wasn't. Didn't mean to mislead. No position never held a position. Only know about $ALT because of $NVO $VKTX and $TERN

User Image Quantumup Posted - 3 days ago

HCW⬇️ $MDGL $390 was $425/Buy Views 1Q24 earnings comments as largely confirming their initial expys around launch: Early payer talks show interest in Rezdiffra, w/ 30% of comm covered lives already secured/on track2reach 80% by YE24: $iva $vktx $lly $nvo etnb akro ions sgmt

User Image Hammrrd Posted - 3 days ago

@Arooba2 that’s valid, only pharma I like is $NVO 👌🏼

Analyst Ratings
Cantor Fitzgerald Overweight Apr 18, 24
BMO Capital Outperform Apr 12, 24
Cantor Fitzgerald Overweight Apr 5, 24
Cantor Fitzgerald Overweight Apr 1, 24
Cantor Fitzgerald Overweight Mar 20, 24
Cantor Fitzgerald Overweight Mar 8, 24
Cantor Fitzgerald Overweight Feb 20, 24
Cantor Fitzgerald Overweight Feb 15, 24
Cantor Fitzgerald Overweight Feb 14, 24